(Q33363358)

26 July 2017

title

Prevalance of heparin-dependent platelet-activating antibodies in preterm newborns after exposure to unfractionated heparin (English)

1 reference

26 July 2017

1 reference

Praveen Kumar

1

1 reference

26 July 2017

Debra A Hoppensteadt

2

1 reference

26 July 2017

M Margaret Prechel

3

1 reference

26 July 2017

Ruth B Deddish

4

1 reference

26 July 2017

Jeanine M Walenga

5

1 reference

26 July 2017

publication date

1 October 2004

1 reference

Clinical and Applied Thrombosis-Hemostasis

26 July 2017

published in

1 reference

26 July 2017

volume

10

1 reference

26 July 2017

issue

4

1 reference

26 July 2017

page(s)

335-339

1 reference

Pathogenicity of IgA and/or IgM antibodies to heparin-PF4 complexes in patients with heparin-induced thrombocytopenia

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Heparin-Induced Thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Littoral cell angioma with severe thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Monitoring therapy with anticoagulants in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Failure of early heparin cessation as treatment for heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

How I treat heparin-induced thrombocytopenia and thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

State-of-the-art patient self-management for control of oral anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Anti-platelet factor 4/heparin antibodies: an independent predictor of 30-day myocardial infarction after acute coronary ischemic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

Heparin-induced thrombocytopenia (HIT) due to heparin flushes: a report of three cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107602960401000405

10.1177/107602960401000405

21 January 2018

Identifiers

DOI

1 reference

26 July 2017

1 reference